Authors:
MESNIL F
MENTRE F
DUBRUC C
THENOT JP
MALLET A
Citation: F. Mesnil et al., POPULATION PHARMACOKINETIC ANALYSIS OF MIZOLASTINE AND VALIDATION FROM SPARSE DATA ON PATIENTS USING THE NONPARAMETRIC MAXIMUM-LIKELIHOOD METHOD, Journal of pharmacokinetics and biopharmaceutics, 26(2), 1998, pp. 133-161
Citation: Aj. Schwab et al., APPLICATION OF THE DISPERSION MODEL FOR DESCRIPTION OF THE OUTFLOW DILUTION PROFILES OF NONELIMINATED REFERENCE INDICATORS IN RAT-LIVER PERFUSION STUDIES, Journal of pharmacokinetics and biopharmaceutics, 26(2), 1998, pp. 163-181
Citation: A. Majumdar, CHARACTERIZATION OF THE DOSE-DEPENDENT TIME OF PEAK EFFECT IN INDIRECT RESPONSE MODELS, Journal of pharmacokinetics and biopharmaceutics, 26(2), 1998, pp. 183-206
Citation: Mo. Karlsson et al., ASSUMPTION TESTING IN POPULATION PHARMACOKINETIC MODELS - ILLUSTRATEDWITH AN ANALYSIS OF MOXONIDINE DATA FROM CONGESTIVE-HEART-FAILURE PATIENTS, Journal of pharmacokinetics and biopharmaceutics, 26(2), 1998, pp. 207-246
Citation: E. Liang et H. Derendorf, PITFALLS IN PHARMACOKINETIC MULTICOMPARTMENT ANALYSIS, Journal of pharmacokinetics and biopharmaceutics, 26(2), 1998, pp. 247-260
Authors:
MARATHE PH
SANDEFER EP
KOLLIA GE
GREENE DS
BARBHAIYA RH
LIPPER RA
PAGE RC
DOLL WJ
RYO UY
DIGENIS GA
Citation: Ph. Marathe et al., IN-VIVO EVALUATION OF THE ABSORPTION AND GASTROINTESTINAL TRANSIT OF AVITRIPTAN IN FED AND FASTED SUBJECTS USING GAMMA-SCINTIGRAPHY, Journal of pharmacokinetics and biopharmaceutics, 26(1), 1998, pp. 1-20
Authors:
NESTOROV IA
AARONS LJ
ARUNDEL PA
ROWLAND M
Citation: Ia. Nestorov et al., LUMPING OF WHOLE-BODY PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS, Journal of pharmacokinetics and biopharmaceutics, 26(1), 1998, pp. 21-46
Citation: Dj. Lunn et L. Aarons, THE PHARMACOKINETICS OF SAQUINAVIR - A MARKOV-CHAIN MONTE-CARLO POPULATION ANALYSIS, Journal of pharmacokinetics and biopharmaceutics, 26(1), 1998, pp. 47-74
Citation: Acf. Keung et al., SINGLE-DOSE PHARMACOKINETICS OF RIFAPENTINE IN WOMEN, Journal of pharmacokinetics and biopharmaceutics, 26(1), 1998, pp. 75-85
Citation: Rc. Gagnon et Jj. Peterson, ESTIMATION OF CONFIDENCE-INTERVALS FOR AREA-UNDER-THE-CURVE FROM DESTRUCTIVELY OBTAINED PHARMACOKINETIC DATA, Journal of pharmacokinetics and biopharmaceutics, 26(1), 1998, pp. 87-102
Citation: A. Yafune et al., A USE OF MONTE-CARLO INTEGRATION FOR POPULATION PHARMACOKINETICS WITHMULTIVARIATE POPULATION-DISTRIBUTION, Journal of pharmacokinetics and biopharmaceutics, 26(1), 1998, pp. 103-123
Authors:
BLAKEY GE
NESTOROV IA
ARUNDEL PA
AARONS LJ
ROWLAND M
Citation: Ge. Blakey et al., QUANTITATIVE STRUCTURE-PHARMACOKINETICS RELATIONSHIPS - I - DEVELOPMENT OF WHOLE-BODY PHYSIOLOGICALLY-BASED MODEL TO CHARACTERIZE CHANGES IN PHARMACOKINETICS ACROSS A HOMOLOGOUS SERIES OF BARBITURATES IN THE RAT (VOL 25, PG 277, 1998), Journal of pharmacokinetics and biopharmaceutics, 26(1), 1998, pp. 131-131
Citation: Gr. Jang et Lz. Benet, ANTIPROGESTIN PHARMACODYNAMICS, PHARMACOKINETICS, AND METABOLISM - IMPLICATIONS FOR THEIR LONG-TERM USE, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 647-672
Authors:
VANSCHAICK EA
DEGREEF HJMM
IJZERMAN AP
DANHOF M
Citation: Ea. Vanschaick et al., PHYSIOLOGICAL INDIRECT EFFECT MODELING OF THE ANTILIPOLYTIC EFFECTS OF ADENOSINE A(1)-RECEPTOR AGONISTS, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 673-694
Citation: M. Tod et al., IMPLEMENTATION AND EVALUATION OF A STOCHASTIC-CONTROL STRATEGY FOR INDIVIDUALIZING TEICOPLANIN DOSAGE REGIMEN, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 695-712
Citation: Rc. Jackson, A PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF CHEMOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION THAT RELATES DEVELOPMENT OF DRUG-RESISTANCE TO TREATMENT INTENSITY, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 713-730
Citation: Kw. Chen et al., A NOTE ON SAMPLE-SIZE DETERMINATION FOR BIOEQUIVALENCE STUDIES WITH HIGHER-ORDER CROSSOVER DESIGNS, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 753-765
Authors:
NARAYANA S
HICHWA RD
PONTO LLB
HURTIG RR
WATKINS GL
Citation: S. Narayana et al., CONSTRUCTION OF A WHOLE-BODY BLOOD-FLOW MODEL FOR USE IN POSITRON-EMISSION-TOMOGRAPHY IMAGING WITH [O-15]WATER, Journal of pharmacokinetics and biopharmaceutics, 25(5), 1997, pp. 539-568
Authors:
VENGPEDERSEN P
WIDNESS JA
WANG J
SCHMIDT RL
Citation: P. Vengpedersen et al., A TRACER INTERACTION METHOD FOR NONLINEAR PHARMACOKINETICS ANALYSIS -APPLICATION TO EVALUATION OF NONLINEAR ELIMINATION, Journal of pharmacokinetics and biopharmaceutics, 25(5), 1997, pp. 569-593
Citation: Ek. Kimanani et D. Potvin, A PARAMETRIC CONFIDENCE-INTERVAL FOR A MOMENT-BASED SCALED CRITERION FOR INDIVIDUAL BIOEQUIVALENCE, Journal of pharmacokinetics and biopharmaceutics, 25(5), 1997, pp. 595-614
Citation: K. Park et al., A SEMIPARAMETRIC METHOD FOR DESCRIBING NOISY POPULATION PHARMACOKINETIC DATA, Journal of pharmacokinetics and biopharmaceutics, 25(5), 1997, pp. 615-642